Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

BACKGROUND: Reducing LDL cholesterol (LDL-C) with statin-based therapy reduces the risk of major atherosclerotic events among patients with chronic kidney disease (CKD), with no evidence of an excess risk of cancer or death from any non-vascular cause. However, non-randomized data have suggested tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Reith, C., Staplin, N., Herrington, W. G., Stevens, W., Emberson, J., Haynes, R., Mafham, M., Armitage, J., Cass, A., Craig, J. C., Jiang, L., Pedersen, T., Baigent, C., Landray, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412040/
https://www.ncbi.nlm.nih.gov/pubmed/28460629
http://dx.doi.org/10.1186/s12882-017-0545-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412040/
https://www.ncbi.nlm.nih.gov/pubmed/28460629
http://dx.doi.org/10.1186/s12882-017-0545-2

Ejemplares similares